Revisions Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Market Closed - Nasdaq 16:00:00 2024-05-02 EDT 5-day change 1st Jan Change
15.92 USD +1.34% Intraday chart for Tourmaline Bio, Inc. +3.31% -39.19%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Revisions Tourmaline Bio, Inc.